Part,  Chapter, Paragraph

 1   II,     5.  5.  3   |          161-7.~Knapp M, McDaid D, Mossialos E, Thornicroft G (2007):
 2   IV,    11.  1.  3   |     tighter regulatory mechanisms (Mossialos and Le Grand, 1999; Cutler,
 3   IV,    11.  1.  4   |         not, or less, able to pay (Mossialos and Thomson 2003) (see Section
 4   IV,    11.  1.  4   |          this additional coverage (Mossialos and Thomson 2004; Colombo
 5   IV,    11.  1.  4   |     subject of debates (Oliver and Mossialos, 2004). Equal access (for
 6   IV,    11.  1.  5   |       control spending (Walley and Mossialos, 2004). While it is difficult
 7   IV,    11.  1.  5   |           prescribing suitability (Mossialos et al, 2004). In the UK,
 8   IV,    11.  1.  5   |       skewing health outcome data (Mossialos et al, 2007).~ ~There are
 9   IV,    11.  1.  5   |       overly bureaucratic schemes (Mossialos et al 2007). Thus, it would
10   IV,    11.  1.  5   |          these could be prevented (Mossialos et al, 2007).~ ~In the US,
11   IV,    11.  1.  6   |         may be up to 25% of costs (Mossialos and Thomson 2004). The costs
12   IV,    11.  3.  2   |          at 26% lower) (Mrazek and Mossialos, 2004). Reference pricing
13   IV,    11.  3.  2   |        only on a short-term basis (Mossialos et al, 2006).~ ~Profit control
14   IV,    11.  3.  2   |         does encourage innovation (Mossialos et al, 2006).~ ~Reimbursement
15   IV,    11.  3.  2   |            Netherlands and Sweden (Mossialos et al, 2006).~ ~The substitution
16   IV,    11.  3.  2   |      quality assurance mechanisms (Mossialos et al, 2005).~ ~Data and
17   IV,    11.  6.  1   |          or increasing efficiency (Mossialos and Dixon, 2002).~ ~Rising
18   IV,    11.  6.  1   |     important to note (Kanavos and Mossialos, 1999).~ ~Table 11.9. Total
19   IV,    11.  6.  2   |             Thomson, Foubister and Mossialos 2008). In addition, local
20   IV,    11.  6.  2   | administrative economies of scale (Mossialos and Dixon, 2002). However,
21   IV,    11.  6.  2   |            public health policies (Mossialos et al, 2000).~ ~Countries
22   IV,    11.  6.  2   |             Thomson, Foubister and Mossialos, 2008) (see Section 11.8.
23   IV,    11.  6.  2   |             Thomson, Foubister and Mossialos 2008). However, the tax
24   IV,    11.  6.  2   |            length from government (Mossialos and Dixon, 2002). However,
25   IV,    11.  6.  2(4)|             Thomson, Foubister and Mossialos 2008).~
26   IV,    11.  6.  2   |             Thomson, Foubister and Mossialos 2008) (see below for more
27   IV,    11.  6.  2   |             Thomson, Foubister and Mossialos 2008).~ ~Relying on health
28   IV,    11.  6.  2   |             Thomson, Foubister and Mossialos 2008).~ ~In France, “general
29   IV,    11.  6.  2   |          in Thomson, Foubister and Mossialos 2008).~ ~The 2006 Health
30   IV,    11.  6.  2   |    Netherlands, Spain and the UK) (Mossialos and Dixon, 2002).~ ~PHI
31   IV,    11.  6.  2   |    supplementary or complementary (Mossialos and Thomson, 2004). Substitutive
32   IV,    11.  6.  2   |         van Doorslaer et al, 2004; Mossialos and Thomson, 2004). Complementary
33   IV,    11.  6.  2   |          complementary insurance) (Mossialos and Thomson, 2004) (Thomson
34   IV,    11.  6.  2   |             Thomson, Foubister and Mossialos 2008).~ ~Following legislative
35   IV,    11.  6.  2   |          in Thomson, Foubister and Mossialos 2008). This widespread increase
36   IV,    11.  6.  2   |          in Thomson, Foubister and Mossialos 2008).~ ~All EU Member States
37   IV,    11.  6.  2   |             Thomson, Foubister and Mossialos 2008).~ ~Although all European
38   IV,    11.  6.  2   |             Thomson, Foubister and Mossialos 2008).~ ~Table 11.13. Examples
39   IV,    11.  6.  3   | redistribution is relatively flat (Mossialos and Dixon, 2002).~ ~Among
40   IV,    11.  6.  4   |             Thomson, Foubister and Mossialos 2008). In Austria and Germany (
41   IV,    11.  6.  4   |             Thomson, Foubister and Mossialos 2008).~ ~Purchasing refers
42   IV,    11.  6.  4   |             Thomson, Foubister and Mossialos 2008). In order to allocate
43   IV,    11.  6.  4   |            Thomson, Foubister, and Mossialos 2008). At the same time,
44   IV,    11.  6.  5   |            Economics.~ ~Kanavos P, Mossialos E (1999): "International
45   IV,    11.  6.  5   |     Community. W.W. Holland and E. Mossialos. Aldershot: Ashgate~ ~Ministry
46   IV,    11.  6.  5   |           Economics 11: 199205.~ ~Mossialos E, Brogan D et al. (2006): "
47   IV,    11.  6.  5   |     Security Review 59(3): 3-25.~ ~Mossialos E, Merkur S et al. (2006):
48   IV,    11.  6.  5   |           Security Institutions.~ ~Mossialos E, Dixon A Eds. (2002):
49   IV,    11.  6.  5   |            Systems and Policies.~ ~Mossialos E, Dixon A et al. (2000): "
50   IV,    11.  6.  5   |            NHS." BMJ 320: 197-8.~ ~Mossialos E, Le Grand J Eds. (1999):
51   IV,    11.  6.  5   |       Union. Ashgate, Aldershot.~ ~Mossialos E, Mrazek M et al. (2004):
52   IV,    11.  6.  5   |      Pharmaceuticals in Europe. E. Mossialos, M. Mrazek and T. Walley.
53   IV,    11.  6.  5   |           Open University Press.~ ~Mossialos E, Thomson S (2004): Voluntary
54   IV,    11.  6.  5   |            Systems and Policies.~ ~Mossialos E, Walley T et al. (2004):
55   IV,    11.  6.  5   |             equity and quality. E. Mossialos, T. Walley and M. Mrazek.
56   IV,    11.  6.  5   |            Systems and Policies.~ ~Mossialos E, Walley T et al. (2005): "
57   IV,    11.  6.  5   |           5(1): 81-93.~ ~Mrazek M, Mossialos E (2004): Regulating pharmaceutical
58   IV,    11.  6.  5   |             equity and quality. E. Mossialos, M. Mrazek and T. Walley.
59   IV,    11.  6.  5   |         Nuffield Trust~ ~Oliver A, Mossialos E (2004): "Equity of access
60   IV,    11.  6.  5   |             options for Europe. E. Mossialos, A. Dixon, J. Figueras and
61   IV,    11.  6.  5   |             options for Europe. E. Mossialos, A. Dixon, J. Figueras and
62   IV,    11.  6.  5   |            of Canada.~ ~Thomson S, Mossialos E et al. (2003): Cost sharing
63   IV,    11.  6.  5   |       Social Affairs.~ ~Thomson S, Mossialos E et al. (2004): Health
64   IV,    11.  6.  5   |      University Press.~ ~Walley T, Mossialos E (2004): Financial incentives
65   IV,    11.  6.  5   |      Pharmaceuticals in Europe. E. Mossialos, M. Mrazek and T. Walley.